PDF herunterladen
Thorac Cardiovasc Surg 2013; 61(04): 330-332
DOI: 10.1055/s-0032-1304551
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Minimal Invasive Retrieval of Dislodged Amplatzer Occluder with Subsequent Impediments

Philipp Born
1   Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
,
Friedrich Eckstein
1   Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
,
Peter Buser
2   Department of Cardiology, University Hospital Basel, Basel, Switzerland
,
Oliver Reuthebuch
1   Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
› Institutsangaben
Weitere Informationen

Publikationsverlauf

25. Oktober 2011

13. Dezember 2011

Publikationsdatum:
25. April 2012 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

A 47-year-old female underwent interventional patent foramen ovale (PFO) closure with an Amplatzer septal occluder (AGA Medical Corporation, USA). After 48 hours of implantation, she experienced intermittent pulse synchronous retrosternal pain. Subsequently, device-associated compression of the aortic root was diagnosed. Occluder retrieval and surgical PFO-closure was accomplished successfully via minimal invasive, video-assisted anterolateral thoracotomy.

Keywords

patent foramen ovale - septal occluder - aorta - anterolateral thoracotomy
 

  • References

  • 1 El-Said HG, Moore JW. Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations?. Catheter Cardiovasc Interv 2009; 73 (7) 925-930
    CrossrefPubMedSuche in Google Scholar
  • 2 Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63 (4) 496-502
    CrossrefPubMedSuche in Google Scholar
  • 3 DiBardino DJ, McElhinney DB, Kaza AK, Mayer Jr JE. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 2009; 137 (6) 1334-1341
    CrossrefPubMedSuche in Google Scholar
  • 4 Chun DS, Turrentine MW, Moustapha A, Hoyer MH. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc Interv 2003; 58 (2) 246-251
    CrossrefPubMedSuche in Google Scholar
  • 5 Lopez-Fernandez T , et al. Aortic wall erosion after percutaneous closure of atrial septal defect. J Am Soc Echocardiogr 2011; 24 (2) 227
    PubMedSuche in Google Scholar
  • 6 Ivens E, Hamilton-Craig C, Aroney C, Clarke A, Jalali H, Burstow DJ. Early and late cardiac perforation by Amplatzer atrial septal defect and patent foramen ovale devices. J Am Soc Echocardiogr 2009; 22 (9) 1067-1070
    PubMedSuche in Google Scholar
  • 7 Baykut D, Doerge SE, Grapow M, Bremerich J, Zerkowski HR. Late perforation of the aortic root by an atrial septal defect occlusion device. Ann Thorac Surg 2005; 79 (3) e28
    CrossrefPubMedSuche in Google Scholar
  • 8 Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005; 45 (8) 1213-1218
    CrossrefPubMedSuche in Google Scholar
  • 9 Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76 (2) 638-648
    CrossrefPubMedSuche in Google Scholar